The O chain polysaccharide (O PS) of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharide is a homopolymer of 2,3-diacetamido-2,3-dideoxygalacturonic acid (GalNAc3NAcA) in which some of the sugars are present as uronamides. The terminal residue contains several unusual modifications. To date, two types of modification have been characterized, and a survey of numerous strains demonstrated that each contained one of these two modification types. Host antibody responses against the O PS are directed against the terminal residue modifications, and there is little cross-reactivity between the two types. This suggests that Bordetella O PS modifications represent a means of antigenic variation. Here we report the characterization of the O PS of B. bronchiseptica strain MO149. It consists of a novel two-sugar repeating unit and a novel terminal residue modification, with the structure Me-4-␣-L-GalNAc3NAcA-(4--D-GlcNAc3NAcA-4-␣-LGalNAc3NAcA-) 5-6 -, which we propose be defined as the B. bronchiseptica O3 PS. We show that the O3 PS is very poorly immunogenic and that the MO149 strain contains a novel wbm (O PS biosynthesis) locus. Thus, there is greater diversity among Bordetella O PSs than previously recognized, which is likely to be a result of selection pressure from host immunity. We also determine experimentally, for the first time, the absolute configuration of the diacetimido-uronic acid sugars in Bordetella O PS.The genus Bordetella currently comprises nine species of Gram-negative bacteria. The most extensively studied of these are the pathogens Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. B. pertussis infects only humans and is the causative agent of whooping cough in infants and persistent respiratory infections in adults (1). B. parapertussis exists as two separate lineages. One is adapted to the human host and causes whooping cough; the other is adapted to the ovine host, in which it can cause chronic pneumonia (2, 3). In contrast, B. bronchiseptica colonizes the respiratory tract of a large number of animals, and although it causes respiratory diseases in some farm, companion, and wild animals, most B. bronchiseptica infections are asymptomatic and chronic (4). B. bronchiseptica is occasionally isolated from the respiratory tract of humans and is probably acquired through contact with infected animals (5).Bordetella lipopolysaccharide (LPS) plays a number of different roles in Bordetella biology, including during infection (e.g. see Refs. 6 -9). We and others have defined the structures of the LPS of these Bordetella (Fig. 1). All three synthesize a very similar LPS core. In B. bronchiseptica and B. pertussis, the core can be further substituted by a trisaccharide to produce the structure referred to as Band A LPS (10, 11). B. parapertussis and B. bronchiseptica, but not B. pertussis, synthesize O PSs.2 Initially, the O PSs of both species were reported to be identical and composed of linear polymers of 1,4-linked GalNAc3NAcA (12), but later it was disc...